- Home
- LEGT vs OCGN Comparison
LEGT vs OCGN Comparison
Compare LEGT & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- OCGN
- Stock Information
- Founded
- LEGT 2023
- OCGN 2013
- Country
- LEGT United States
- OCGN United States
- Employees
- LEGT N/A
- OCGN N/A
- Industry
- LEGT
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LEGT
- OCGN Health Care
- Exchange
- LEGT Nasdaq
- OCGN Nasdaq
- Market Cap
- LEGT 277.1M
- OCGN 283.3M
- IPO Year
- LEGT 2024
- OCGN N/A
- Fundamental
- Price
- LEGT $10.74
- OCGN $1.09
- Analyst Decision
- LEGT
- OCGN Strong Buy
- Analyst Count
- LEGT 0
- OCGN 3
- Target Price
- LEGT N/A
- OCGN $6.00
- AVG Volume (30 Days)
- LEGT 10.9K
- OCGN 6.6M
- Earning Date
- LEGT 01-01-0001
- OCGN 08-01-2025
- Dividend Yield
- LEGT N/A
- OCGN N/A
- EPS Growth
- LEGT N/A
- OCGN N/A
- EPS
- LEGT 0.35
- OCGN N/A
- Revenue
- LEGT N/A
- OCGN $4,522,000.00
- Revenue This Year
- LEGT N/A
- OCGN N/A
- Revenue Next Year
- LEGT N/A
- OCGN N/A
- P/E Ratio
- LEGT $0.88
- OCGN N/A
- Revenue Growth
- LEGT N/A
- OCGN N/A
- 52 Week Low
- LEGT $10.15
- OCGN $0.52
- 52 Week High
- LEGT $10.86
- OCGN $1.67
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- OCGN 54.73
- Support Level
- LEGT N/A
- OCGN $0.99
- Resistance Level
- LEGT N/A
- OCGN $1.18
- Average True Range (ATR)
- LEGT 0.00
- OCGN 0.08
- MACD
- LEGT 0.00
- OCGN 0.00
- Stochastic Oscillator
- LEGT 0.00
- OCGN 54.55
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").